COVID-19 infection is growing in a rapid rate. Due to unavailability of specific drugs, early detection of (COVID-19) patients is essential for disease cure and control. There is a vital need to detect the disease at early stage and instantly quarantine the infected people. Many research have been going on, however, none of them introduces satisfactory results yet. In spite of its simplicity, K-Nearest Neighbor (KNN) classifier has proven high flexibility in complex classification problems. However, it can be easily trapped. In this paper, a new COVID-19 diagnose strategy is introduced, which is called COVID-19 Patients Detection Strategy (CPDS). The novelty of CPDS is concentrated in two contributions. The first is a new hybrid feature selection Methodology (HFSM), which elects the most informative features from those extracted from chest Computed Tomography (CT) images for COVID-19 patients and non COVID-19 peoples. HFSM is a hybrid methodology as it combines evidence from both wrapper and filter feature selection methods. It consists of two stages, namely; Fast Selection Stage (FS 2 ) and Accurate Selection Stage (AS 2 ). FS 2 relies on filter, while AS 2 uses Genetic Algorithm (GA) as a wrapper method. As a hybrid methodology, HFSM elects the significant features for the next detection phase. The second contribution is an enhanced K-Nearest Neighbor (EKNN) classifier, which avoids the trapping problem of the traditional KNN by adding solid heuristics in choosing the neighbors of the tested item. EKNN depends on measuring the degree of both closeness and strength of each neighbor of the tested item, then elects only the qualified neighbors for classification. Accordingly, EKNN can accurately detect infected patients with the minimum time penalty based on those significant features selected by HFSM technique. Extensive experiments have been done considering the proposed detection strategy as well as recent competitive techniques on the chest CT images. Experimental results have shown that the proposed detection strategy outperforms recent techniques as it introduces the maximum accuracy rate.
COVID-19, as an infectious disease, has shocked the world and still threatens the lives of billions of people. Early detection of COVID-19 patients is an important issue for treating and controlling the disease from spreading. In this paper, a new strategy for detecting COVID-19 infected patients will be introduced, which is called Distance Biased Naïve Bayes (DBNB). The novelty of DBNB as a proposed classification strategy is concentrated in two contributions. The first is a new feature selection technique called Advanced Particle Swarm Optimization (APSO) which elects the most informative and significant features for diagnosing COVID-19 patients. APSO is a hybrid method based on both filter and wrapper methods to provide accurate and significant features for the next classification phase. The considered features are extracted from Laboratory findings for different cases of people, some of whom are COVID-19 infected while some are not. APSO consists of two sequential feature selection stages, namely; Initial Selection Stage (IS 2 ) and Final Selection Stage (FS 2 ). IS 2 uses filter technique to quickly select the most important features for diagnosing COVID-19 patients while removing the redundant and ineffective ones. This behavior minimizes the computational cost in FS 2 , which is the next stage of APSO. FS 2 uses Binary Particle Swarm Optimization (BPSO) as a wrapper method for accurate feature selection. The second contribution of this paper is a new classification model, which combines evidence from statistical and distance based classification models. The proposed classification technique avoids the problems of the traditional NB and consists of two modules; Weighted Naïve Bayes Module (WNBM) and Distance Reinforcement Module (DRM). The proposed DBNB tries to accurately detect infected patients with the minimum time penalty based on the most effective features selected by APSO. DBNB has been compared with recent COVID-19 diagnose strategies. Experimental results have shown that DBNB outperforms recent COVID-19 diagnose strategies as it introduce the maximum accuracy with the minimum time penalty.
Breast cancer, which is also the leading cause of death among women, is one of the most common forms of the disease that affects females all over the world. The discovery of breast cancer at an early stage is extremely important because it allows selecting appropriate treatment protocol and thus, stops the development of cancer cells. In this paper, a new patients detection strategy has been presented to identify patients with the disease earlier. The proposed strategy composes of two parts which are data preprocessing phase and patient detection phase (PDP). The purpose of this study is to introduce a feature selection methodology for determining the most efficient and significant features for identifying breast cancer patients. This method is known as new hybrid feature selection method (NHFSM). NHFSM is made up of two modules which are quick selection module that uses information gain, and feature selection module that uses hybrid bat algorithm and particle swarm optimization. Consequently, NHFSM is a hybrid method that combines the advantages of bat algorithm and particle swarm optimization based on filter method to eliminate many drawbacks such as being stuck in a local optimal solution and having unbalanced exploitation. The preprocessed data are then used during PDP in order to enable a quick and accurate detection of patients. Based on experimental results, the proposed NHFSM improves the efficiency of patients’ classification in comparison with state-of-the-art feature selection approaches by roughly 0.97, 0.76, 0.75, and 0.716 in terms of accuracy, precision, sensitivity/recall, and F-measure. In contrast, it has the lowest error rate value of 0.03.
Breast cancer is one of the most common types of cancer that affects women globally and it is the primary cause of death. Early detection of breast cancer is a vital process that can facilitate appropriate treatment, stop the progression of cancer cells, and reduce morbidity and mortality. Artificial Intelligence (AI) and Machine Learning (ML) are the most popular methods that can be used to detect and classify breast cancer accurately. In this paper, a new strategy for classifying breast cancer using Neutrosophic Techniques (NTs) and machine learning techniques is introduced, which is called Breast Cancer Classification Strategy (BC2S). The proposed BC2S consists of two phases, which are; Data Preprocessing Phase (DP2) and Breast Cancer Classification Phase (BC2P). The main aim of the data preprocessing phase is to; (i) extract features from mammogram images and then remove the outlier items, (ii) select the most effective and informative features from those extracted features using new feature selection method called Efficient Ant Colony Optimization (EACO), and (iii) convert the selected features from classical domain into neutrosophic domain using NTs to give accurate classification through the next classification phase BC2P. The proposed classification model uses Deep Neural Network (DNN) to determine whether the patient is normal or infected with benign or malignant cancer. According to experimental results, the proposed strategy outperforms other competitors in terms of accuracy, precision, recall, and F-measure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.